Awards

Grants and Awards

2010/8 - 2028/12, BC Leading Edge Endowment Fund, LEEF Chair, Research Chair, Funding Source: Leading Edge Endowment Fund (Principal Investigator)

2015/1 - 2018/12, Biomarkers for Crossing the Translational Drivid in Acute Spinal Cord Injury, Funding Source: Brain Canada (Co-applicant)

2013/1 - 2018/12, The BC Proteomics Network, Funding Source: Michael Smith Foundation for Health Research (Principal Investigator)

2013/6 - 2018/5, Research Program in Structural Proteomics to Characterize Misfolded Proteins, Funding Source: Natural Sciences and Engineering Research Council of Canada – NSERC (Principal Investigator)

2015/10 - 2017/9, The Metabolomics Innovation Centre, Funding Source: Genome Canada (Principal Investigator)

2013/4 - 2017/3, Reducing stroke burden with hospital- ready biomarker test for rapid TIA triage, Funding Source: Genome Canada (Principal Investigator)

2015/4 - 2017/3, The Proteomics Centre (PC): An integrated GIN Node for Comprehensive, Innovative, Funding Source: Genome Canada Technology Development Funds for Nodes of the Genomics Innovation Network (Principal Investigator)

2014/1 - 2017/1, Functional analyses of 150 non-annotated genes in an industrial wine strain of saccharomyces cerevisiae, Funding Source:  Natural Sciences and Engineering Research Council of Canada – NSERC (Co-applicant)

2014/10 - 2016/3, Development of Disease Biomarker Assessment Assays and Kits for Targeted Quantitative Proteomics of Mouse Plasma by Mass Spectrometry, Funding Source: Genome Canada (Principal Investigator)

2014/9 - 2015/8, Improved detection of testosterone doping through proteomic analysis of dried blood spots, Funding Source: The Partnership for Clean Competition (Principal Investigator)

2013/4 - 2015/3, S & T Innovation Centre, The Metabolomics Innovation, Funding Source: Genome Canada (Principal Investigator)

2013/4 - 2015/3, S & T Innovation Centre, UVic Genome BC Proteomics Centre, Funding Source: Genome Canada (Principal Investigator)

2013/4 - 2015/3, Clinical Implementation and Outcomes Evaluation of Blood-based Biomarkers for COPD Management, Funding Source: Genome Canada (Co-investigator)

2012/4 - 2014/3, Next-generation Integrated Pest Management Tools for Beekeeping, Funding Source: Genome Canada (Collaborator)

2012/4 - 2014/3, SMarTForest, Spruce Marker Technologies for Sustainable Forestry, Funding Source: Genome Canada (Co-investigator)

2011/4 - 2013/3, S & T Innovation Centre, UVic Genome BC Proteomics Centre, Funding Source: Genome Canada (Principal Investigator)

2011/4 - 2013/3, S & T Innovation Centre, The Metabolomics Innovation, Funding Source: Genome Canada (Principal Investigator)

2009/1 - 2012/12, Assessment of nanosilver on the bioactivity of municipal wastewater effluent, Funding Source: Natural Sciences and Engineering Research Council of Canada – NSERC (Co-investigator)

2011/10 - 2012/9, Development and Commercialization of Standardized Reagents for Masspectrometry based Proteomics, Funding Source: Genome British Columbia (Principal Investigator)

2011/6 - 2012/5, Structural Proteomics of Prion Aggregates, Funding Source: Networks of Centres of Excellence (NCE) Prionet (Principal Investigator)

2007/3 - 2012/3, The BC Proteomics Network, Funding Source: Michael Smith Foundation for Health Research (Principal Investigator)

2010/4 - 2012/3, Infrastructure Investment at the UVic Genome BC Proteomics Centre, Funding Source: Western Economic Diversification Canada (Principal Investigator)

2009/1 - 2012/1, Grape and Wine Genomics, Funding Source: Genome Canada (Co-investigator)

2011/1 - 2011/12, Acquisition of a mass spectrometer and biomarker discovery instrument, Funding Source: Western Economic Diversification Canada (Principal Investigator)

2010/10 - 2011/9, Development of a high-throughput proteomics platform for biomarker verification, Funding Source: Genome British Columbia (Principal Investigator)

2008/8 - 2011/8, Phosphoproteome analysis of Leishmania donovani differentiation, Funding Source: Israeli Ministry of Health, Israel (Co-investigator)

2009/8 - 2011/8, Targeting the Leishmania kinome for the development of novel anti-parasitic strategies, Funding Source: The European Commission (Co-investigator)

2006/9 - 2011/8, Measurement of cancer biomarker candidates using targeted MS methodology, Funding Source: National Cancer Institute, USA (Co-investigator)

2009/1 - 2011/6, Science and Technology Platform Funding, Competition III, Funding Source: Genome Canada (Principal Investigator)

2009/4 - 2011/3, Establishing a Centre for MALDI based Tissue Imaging, Funding Source: Western Economic Diversification Canada (Principal Investigator)

2009/6 - 2011/3, Statistical Validation of Biomarkers and Clinical Assay Development for Cardiovascular Disease, Funding Source: Networks of Centres of Excellence – NCE (Principal Investigator)

2006/11 - 2010/11, UVic Genome BC Proteomics Centre, Funding Source: University of Victoria (Principal Investigator)

2008/6 - 2010/6, MS-based Structural Proteomics for Drug Development and Design, Funding Source: Genome Canada (Principal Investigator)

2009/7 - 2010/6, Establishment of Comprehensive Metabolite Analysis at the UVic Genome BC, Proteomics Centre, Funding Source: Western Economic Diversification Canada (Principal Investigator)

2009/4 - 2010/3, frogSCOPE, Funding Source: Genome British Columbia (Co-investigator)

2009/4 - 2010/3, Systems Biology Approaches to Immunotherapy, Funding Source: Canadian Institutes of Health Research – CIHR (Co-investigator)

2009/1 - 2009/12, Establishing MRM as a high throughput mass spectrometry based proteomics approach for protein biomarker discovery and validation, Funding Source: BC Proteomics Network – BCPN (Principal Investigator)

2005/7 - 2008/12, Science&Technology Platform Funding, Funding Source: Genome Canada (Principal Investigator)

2006/5 - 2008/4, Spindle Formation and Function in Ococytes and Early Embryos, Funding Source: National Institutes of Health – NIH, USA (Co-investigator)

2006/6 - 2007/6, Acquisition of a Maldi-Tof/Tof Mass Spectrometer, Funding Source: Genome Canada (Principal Investigator)

2006/1 - 2006/12, Proteomic and Metabolomic Biomarkers of CF Lung Disease, Funding Source: Cystic Fibrosis Foundation (Principal Investigator)

2002/1 - 2006/8, Cancer Centre Core Support Grant, Funding Source: National Institutes of Health – NIH, USA (Principal Investigator)

2001/3 - 2006/8, Equipment Start-up Fund, Funding Source: University of North Carolina (Principal Investigator)

2001/3 - 2006/8, Start-up Funds, Funding Source: University of North Carolina (Principal Investigator)

2002/1 - 2006/8, Molecular Regulation in Reproduction, Funding Source: National Institutes of Health – NIH, USA (Principal Investigator)

2006/1 - 2006/8, Cochlear Nucleus Proteomics in a Mouse Model of Age-Related Hearing Loss, Funding Source: National Institutes of Health – NIH, USA (Principal Investigator)

2004/1 - 2006/8, CEHS Biomarker Core Facility, Funding Source: National Institutes of Health – NIH, USA (Principal Investigator)

2005/6 - 2006/5, Acquisition of MALDI-source for an Ultra-high Resolution Mass Spectrometer, Funding Source: North Carolina Biotechnology Center (Principal Investigator)

2005/4 - 2006/3, Acquisition of an Ultra-high Resolution Mass Spectrometer, Funding Source: National Institutes of Health – NIH, USA (Principal Investigator)

2002/3 - 2005/2, Discovery of Novel Proteins that Associate with CFTR, Funding Source: Cystic Fibrosis Foundation (Principal Investigator)

2002/9 - 2004/8, Binding Network of Pol Eta in DNA Damage Response, Funding Source:  National Institutes of Health – NIH, USA (Principal Investigator)